CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Cash flows from operating activities:
Net loss	$ (17,376)	$ (75,903)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	42,886	41,235
Amortization of deferred financing costs	2,300	2,150
Accretion of below- and amortization of above-market lease liabilities and assets, net	(3,966)	(4,719)
Vesting of asset management fees	0	11,500
Equity-based compensation	2,437	2,074
Loss on fair value of the listing promote and other derivatives	4	38,099
Loss (income) from unconsolidated joint venture	(805)	1,036
Gain on sale of investment securities	(48)	0
Bad debt expense	556	66
Changes in assets and liabilities:
Tenant and other receivables	89	(2,252)
Unbilled rent receivables	(8,726)	(6,081)
Prepaid expenses, other assets and deferred costs	(3,274)	1,524
Accrued unbilled ground rent	1,774	2,174
Accounts payable and accrued expenses	550	(4,972)
Due from affiliated entities		(1,041)
Deferred rent and other liabilities	(69)	(2,738)
Net cash provided by operating activities	16,332	2,152
Cash flows from investing activities:
Proceeds from sale of preferred equity investment	35,100	0
Acquisition funds released from escrow	4,551	0
Additional investment in unconsolidated joint venture and preferred equity investment	0	(3,872)
Capital expenditures	(12,940)	(2,868)
Distributions from unconsolidated joint venture	0	5,177
Proceeds from sale of investment securities	1,098	0
Purchase of investment securities	(42)	(3,000)
Net cash provided by (used in) investing activities	27,767	(4,563)
Cash flows from financing activities:
Payments on mortgage notes payable	(244)	(234)
Payments of financing costs	(157)	(7,258)
Proceeds from issuance of common stock	0	11,311
Repurchases of common stock, inclusive of fees and expenses	0	(154,269)
Payments of offering costs and fees related to stock issuances	0	(1,462)
Dividends paid	(37,305)	(28,830)
Distributions to non-controlling interest holders	(1,361)	(98)
Proceeds from issuance of operating partnership units	0	750
Restricted cash	(58)	(260)
Net cash used in financing activities	(39,125)	(180,350)
Net increase (decrease) in cash and cash equivalents	4,974	(182,761)
Cash and cash equivalents, beginning of period	22,512	233,377
Cash and cash equivalents, end of period	27,486	50,616
Supplemental disclosures:
Cash paid for interest	9,761	6,630
Dividends payable	48	0
Accrued capital expenditures	2,546	0
Conversion of OP units to common stock	974	0
Common stock issued through distribution reinvestment plan	$ 0	$ 19,019